Adenosine receptor targeting in health and disease
- PMID: 22017198
- DOI: 10.1517/13543784.2011.627853
Adenosine receptor targeting in health and disease
Abstract
Introduction: The adenosine receptors A(1), A(2A), A(2B) and A(3) are important and ubiquitous mediators of cellular signaling that play vital roles in protecting tissues and organs from damage. In particular, adenosine triggers tissue protection and repair by different receptor-mediated mechanisms, including increasing the oxygen supply:demand ratio, pre-conditioning, anti-inflammatory effects and the stimulation of angiogenesis.
Areas covered: The state of the art of the role of adenosine receptors which have been proposed as targets for drug design and discovery, in health and disease, and an overview of the ligands for these receptors in clinical development.
Expert opinion: Selective ligands of A(1), A(2A), A(2B) and A(3) adenosine receptors are likely to find applications in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature. The aim of this review is to provide an overview of the present knowledge regarding the role of these adenosine receptors in health and disease.
Similar articles
-
Adenosine receptors in health and disease.Adv Pharmacol. 2011;61:41-75. doi: 10.1016/B978-0-12-385526-8.00002-3. Adv Pharmacol. 2011. PMID: 21586355 Review.
-
Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.Expert Opin Ther Targets. 2014 May;18(5):527-39. doi: 10.1517/14728222.2014.888416. Epub 2014 Mar 1. Expert Opin Ther Targets. 2014. PMID: 24579961 Review.
-
Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.Annu Rev Pharmacol Toxicol. 2001;41:775-87. doi: 10.1146/annurev.pharmtox.41.1.775. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264476 Review.
-
Adenosine, an endogenous distress signal, modulates tissue damage and repair.Cell Death Differ. 2007 Jul;14(7):1315-23. doi: 10.1038/sj.cdd.4402132. Epub 2007 Mar 30. Cell Death Differ. 2007. PMID: 17396131 Review.
-
Adenosinergic cardioprotection: multiple receptors, multiple pathways.Pharmacol Ther. 2007 May;114(2):208-21. doi: 10.1016/j.pharmthera.2007.02.004. Epub 2007 Mar 12. Pharmacol Ther. 2007. PMID: 17408751 Review.
Cited by
-
Molecular Simulations and Drug Discovery of Adenosine Receptors.Molecules. 2022 Mar 22;27(7):2054. doi: 10.3390/molecules27072054. Molecules. 2022. PMID: 35408454 Free PMC article. Review.
-
Purinergic receptors in ocular inflammation.Mediators Inflamm. 2014;2014:320906. doi: 10.1155/2014/320906. Epub 2014 Jul 14. Mediators Inflamm. 2014. PMID: 25132732 Free PMC article. Review.
-
Probing GPCR structure: adenosine and P2Y nucleotide receptors.Methods Enzymol. 2013;520:199-217. doi: 10.1016/B978-0-12-391861-1.00009-5. Methods Enzymol. 2013. PMID: 23332701 Free PMC article.
-
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A1/A2B Partial Agonists.Pharmaceuticals (Basel). 2019 Oct 22;12(4):159. doi: 10.3390/ph12040159. Pharmaceuticals (Basel). 2019. PMID: 31652622 Free PMC article.
-
Adenosine receptors as drug targets--what are the challenges?Nat Rev Drug Discov. 2013 Apr;12(4):265-86. doi: 10.1038/nrd3955. Nat Rev Drug Discov. 2013. PMID: 23535933 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources